Uncommon yeast infections in hematological patients: from diagnosis to treatment.

Author: CairaMorena, LeoneGiuseppe, PaganoLivio, TrecarichiEnrico Maria, TumbarelloMario

Paper Details 
Original Abstract of the Article :
Invasive fungal diseases have been recognized with increasing frequency as major pathogens in patients with cancer over the past few decades, as a result of new and more aggressive anticancer treatments and supportive care, and this has been especially reported for patients suffering from hematologi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1586/eri.11.124

データ提供:米国国立医学図書館(NLM)

Addressing Uncommon Yeast Infections in Hematological Patients

Invasive fungal diseases have become increasingly prevalent in patients with cancer, especially those with hematological malignancies. This research examines the emergence of uncommon yeasts as significant human pathogens in these patients. The study focuses on the epidemiology, diagnosis, treatment, and the role of novel antifungal drugs for invasive fungal diseases caused by Trichosporon spp., Blastomyces spp., and Cryptococcus spp. in hematological patients.

The Challenge of Uncommon Yeast Infections in Hematological Patients

The study highlights the significant challenge posed by uncommon yeasts as opportunistic pathogens in hematological patients. These infections often present as breakthrough infections, resistant to empirical antifungal therapies or prophylaxis, and can lead to high mortality rates. The authors emphasize the need for a comprehensive approach to diagnosis and treatment of invasive fungal diseases in this vulnerable patient population.

The Importance of Early Diagnosis and Effective Treatment

The research underscores the critical importance of early diagnosis and effective treatment for invasive fungal diseases in hematological patients. Prompt identification of the causative organism and initiation of appropriate antifungal therapy can significantly improve patient outcomes.

Dr. Camel's Conclusion

This research provides valuable insights into the evolving landscape of fungal infections in hematological patients. The study highlights the importance of recognizing the emergence of uncommon yeasts as significant pathogens and developing effective strategies for diagnosis and treatment. It's like exploring a vast desert, carefully navigating the changing terrain of fungal infections to ensure optimal patient care.

Date :
  1. Date Completed 2012-02-15
  2. Date Revised 2011-10-27
Further Info :

Pubmed ID

22029524

DOI: Digital Object Identifier

10.1586/eri.11.124

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.